
Beijing Hotgen Biotech Co., Ltd remote work and careers
Advanced Manufacturer of IVD Products
About Beijing Hotgen Biotech Co., Ltd
Hotgen Biotech Co., Ltd was founded in 2005 and is located in the Biomedical Base of Zhongguancun High-Tech Park in Beijing. It is a national-level high-tech company dedicated to developing and manufacturing innovative in-vitro diagnostic (IVD), point-of-care testing (POCT), and biodefense products. Now, Hotgen has four technology platforms: 1. Chemiluminescence Immunoassay CLIA System. ( MQ60 and MQ plus) Test parameters: 1) Cardiac: hs-cTnI, CK-MB, MYO, H-FABP, NT-proBNP, D-Dimer, Lp-PLA2 2) Inflammation Monitoring: CRP, PCT, IL-6 3) Kidney Function: NGAL, Cys-C 4) Tumor Marker: AFP, GP73, AFP-L3, DCP 5) Bone Metabolism: 25-OH-Vitamin D 2. Up-converting Phospher Immunoassay Test System. ( UPT-3A) 1) Cardiac: cTnI, CK-MB, MYO, H-FABP, NT-proBNP, D-Dimer, Lp-PLA2 3) Kidney Function: NGAL 4) Liver Function: AFP, GP73 5) Premature Birth: fFN 6) Rheumatoid Arthritis: anti-CCP 3. Colloidal Gold Semi-quantitative Rapid Test PCT, anti-CCP, NT-proBNP, H-FABP, fFN, TP-Ab/IgM, NS1, IgM/IgG, combo NS1+IgM/IgG, Typhoid fever, Malaria Pf/Pv 4. Enzyme-Linked Immunosorbent Assay (ELISA) Test System Anti-CCP, AMH, DCP, CA125, AFP, CEA, PSA, Lp-PLA2, GP73, HBV-LP, HE4
Mission and direction
Hotgen Biotech develops and manufactures innovative in-vitro diagnostic and point-of-care testing solutions, alongside biodefense products, serving global healthcare needs through advanced assay platforms, diagnostic reagents, instruments, and supporting consumables. The company focuses on improving disease detection, monitoring, and clinical decision-making with reliable, high-performance diagnostic technologies.
Company values
- Innovation
- Quality Focus
- Global Reach
- Customer Centric
- Collaboration
- Scientific Rigor